Download PDF
Horm Metab Res 1985; 17(10): 518-521
DOI: 10.1055/s-2007-1013593
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Insulin Resistance in Cushing's Syndrome

E. Karnieli, P. Cohen, N. Barzilai, Z. Ish-Shalom, M. Armoni, R. Rafaelov, D. Barzilai
  • Metabolic Unit, Endocrine Institute, Department of Medicine C, Rambam Medical Center, and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Further Information

Publication History

1984

1984

Publication Date:
14 March 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Insulin resistance is well established in Cushing's syndrome, but its mechanisms are not completely under-stood. We performed the euglycemic insulin clamp technique on four patients with Cushing's syndrome, five obese patients and five normal volunteers, in order to determine the role of impairments in insulin responsiveness and insulin clearance in hypercorticism and obesity. Insulin was infused at 0.3, 1, 3 and 10 mU/kg/min, and steady-state glucose-infusion rates required to maintain euglycemia were determined. Glucose disposal at maximal insulin levels was 11.9 ± 0.4 mg/kg/min in normals, with a 29% decrease in obese and a 42% decrease in Cushing's syndrome patients. Half maximally effective insulin concentrations were increased in both abnormal groups compared to normals. Maximal insulin clearance rates were 1460 ± 200 ml/min/m2 in normals, not significantly changed in obese and 40% decreased in Cushing's syndrome patients. These results indicate that the insulin resistance in Cushing's syndrome is distinct from that occurring in obesity and is characterized by both decreased insulin responsiveness and decreased insulin clearance. These impairments could be caused by a common defect which may be at or distal to the glucose transport level.

Key-Words:

Insulin Resistance - Cushing's Syndrome - Obesity - Euglycemic Clamp - Insulin Clearance - Glucose Transport - Postreceptor Defect

      >